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ABSTRACT 
Background: A diagnosis of Dissociative identity disorder (DID) is controversial and prone 
to under- and misdiagnosis. From the moment of seeking treatment for symptoms to the 
time of an accurate diagnosis of DID individuals received an average of four prior other 
diagnoses and spent seven years, with reports of up to twelve years, in mental health 
services. 
Aim: To investigate whether data-driven pattern recognition methodologies applied to 
structural brain images can provide biomarkers to aid DID diagnosis.  
Method: Structural brain images of 75 participants were included; 32 female individuals 
with DID and 43 matched healthy controls. Individuals with DID were recruited from 
psychiatry and psychotherapy outpatient clinics. Probabilistic pattern classifiers were trained 
to discriminate cohorts based on measures of brain morphology.  
Results: The pattern classifiers were able to accurately discriminate between individuals 
with DID and healthy controls with high sensitivity (72%) and specificity (74%) on the basis 
of brain structure. These findings provide evidence for a biological basis for distinguishing 
between DID affected and healthy individuals.  
Conclusions: We propose a pattern of neuroimaging biomarkers that could be used to 
inform the identification of individuals with DID from healthy controls at the individual level. 
This is important and clinically relevant because the DID diagnosis is controversial and 
individuals with DID are often misdiagnosed. Ultimately, the application of pattern recognition 
methodologies could prevent unnecessary suffering of individuals with DID because of an 
earlier accurate diagnosis, which will facilitate faster and targeted interventions.  
 
 
Declaration of interest: The authors declare no competing financial interests.  
 
Access to data: Antje A.T. S. Reinders confirms to have access to all the data in the study.
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INTRODUCTION 
Dissociative identity disorder (DID)1 is probably the most disputed psychiatric disorder2,3. 
DID is the most severe of dissociative disorders and involves two or more dissociative 
personality states, recurrent gaps in the recall of everyday events or important personal 
information, and/or traumatic events that are inconsistent with ordinary forgetting, and is not 
related to substance abuse or general medication. For decades the disorder has been 
officially recognized in the Diagnostic and Statistical Manual of Mental Disorders (DSM) (in 
the DSM-III (1980) as Multiple Personality Disorder), but many patients with DID share a 
history of years of misdiagnoses, inefficient pharmacological treatment, and several 
hospitalizations4. To date, many clinicians and scientists still question the validity and even 
the very existence of DID5,6. Unfamiliarity with the spectrum of dissociative disorders and 
lack of knowledge and appreciation of its epidemiology7, the existence of imitative DID, as 
well as the reluctance of individuals with DID to present their dissociative symptoms, often 
due to feelings of shame, may lead to the validity concerns and under- and misdiagnosis of 
DID. Years of incorrect treatment results in protracted personal suffering and high direct and 
indirect societal costs8,9. Structural brain imaging holds promise to aid disease diagnosis by 
providing objective biomarkers at the single subject level10, thereby paving the way for a fast 
and correct diagnosis of individuals with DID. The current study presents a first step towards 
an automated classification of individuals with DID by investigating whether individuals with 
DID can be separated from healthy controls on the basis of neuroimaging markers, thus 
informing DID’s neuroanatomical basis in terms of grey and white matter of the brain.  
 Skeptics of DID assume that dissociative symptoms can easily be simulated by 
normal healthy individuals, which comprises the Fantasy Model of DID11. Several pioneering 
functional brain imaging studies from our group have shown that individuals with genuine 
DID can be distinguished from healthy controls simulating DID12–14, but critics could still 
argue that subjects can manipulate their brain activity15,16. As neuroanatomical data is 
unlikely to be subject to cognitive manipulation, in this study we investigate whether patients 
with DID can be separated from healthy controls at the individual subject level on the basis 
of neuroanatomical biomarkers by employing a multivariate data driven pattern recognition 
approach. We used a probabilistic pattern recognition approach10 that allowed us to 
investigate the diagnostic value of grey and white matter of the brain in a comparatively 
large sample of individuals with DID as compared to healthy controls and to quantify the 
degree to which the brain phenotype of DID patients can be distinguished from those of 
healthy subjects. This study is important in two ways: 1) it provides evidence as to whether 
genuine DID can be distinguished from normal healthy individuals on the basis of their brain 
morphology, thereby addressing the core of the Fantasy Model for DID, and 2) it provides 
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neuroanatomical biomarkers that could support the development of pattern recognition 
methodologies to be used as a clinically useful aid for the diagnostic accuracy of DID.  
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METHODS 
Subjects 
Magnetic resonance imaging (MRI) data from 75 participants were obtained in the 
Netherlands in the University Medical Centre in Groningen (UMCG, the Netherlands) and 
the Amsterdam Medical Centre (AMC, the Netherlands), and in Switzerland at the University 
Hospital in Zurich (USZ). Details of these two samples have previously been published 
elsewhere: Chalavi et al.17,18 (Dutch sample), Schlumpf et al.12,13 (Swiss/German sample), 
and Reinders et al.19 (combined). All participants gave informed written consent in 
accordance with the Declaration of Helsinki and as dictated by ethics approval obtained by 
the Medical Ethical Committees (METc) of the University Medical Center Groningen (UMCG) 
and the Amsterdam Medical Center (AMC), and by the cantonal ethical commission of 
Zurich.  
 Overall, 32 women with DID were recruited from private practitioners of psychiatry and 
psychotherapy and psychiatric outpatient departments and initially diagnosed according to 
DSM-IV criteria for DID20. The clinical diagnosis was subsequently confirmed by independent 
expert clinicians using the Structural Clinical Interview for DSM-IV Dissociative Disorders 
(SCID-D)21,22, specifically to avoid the inclusion of imitative DID23. DID is known to be highly 
comorbid24,25. In the current study PTSD co-morbidity was debriefed using the SCID-D and it 
was found that out of the 32 DID individuals 29 individuals had co-morbid PTSD and 3 
individuals had PTSD in remission. The following information concerning other comorbid 
disorders was obtained based on DSM-IV classification [American Psychiatric Association, 
1994] from the participants and/or their personal therapists (N=29): no other comorbid 
disorders (N=13), somatoform disorder (N=2), depression (chronic N=1, recurrent N=10), 
dysthymic disorder (N=1), specific phobias (N=3), panic disorder (N=3), anxiety disorder 
(N=1), obsessive compulsive disorder (N=1), personality disorders (not otherwise specified 
(N=2), mixed (N=2), borderline personality disorder (N=5), dependent and histrionic (N=1)), 
eating disorder (N=3), sleeping disorder (N=2), catalepsy (N=1), psychogenic seizures 
(N=1), and attention deficit disorder (N=1). Of note, as approximately half of the DID 
subjects did not have any other co-morbidities than PTSD and other co-comorbidities were 
more randomly distributed across the sample, it is unlikely that these contribute to the 
classifier in a systematic manner. Nevertheless, even if there is an influence of co-morbidity 
on classification then our results are likely to represent an underestimation of classification 
strength and a more homogeneous sample would increase the sensitivity and specificity. 
 The DID and healthy control (HC) group were carefully matched for demographics 
including age, gender (all female), years of education, and Western European ancestry. As 
previously shown19, we indeed did not find any significant differences between patients and 
HCs with respect to age or education (see Supplementary Table 1). As part of the inclusion it 
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was confirmed that all HCs were free of medication and psychiatric disorders. Furthermore, 
they scored below a critical cut-off of 25 on the Dissociative Experiences Scale (DES26) and 
29 on the Somatoform Dissociation Questionnaire (SDQ-2027). Depersonalization symptoms 
were assessed using the Cambridge Depersonalization Scale (CDS28). Traumatic 
experiences were measured with the Traumatic Experience Checklist (TEC29). As expected 
and previously reported19, psychoform and somatoform dissociative symptoms and 
depersonalization scores were significantly higher in the DID group as compared to HCs (all 
p values < 0.001). Individuals with DID also scored significantly higher compared to the 
controls for traumatic experiences (all p values < 0.001) on all five adverse life event 
categories, namely emotional neglect, emotional abuse, physical abuse, sexual abuse, and 
sexual harassment (see Supplementary Table 1). 
 
MRI 
Data Acquisition 
All data were obtained on 3-T Philips whole-body MRI scanners (Philips Medical Systems, 
Best, NL) in one of the three participating centers. An optimized structural MRI protocol30 
with high reproducibility between centers was used at all three centers and T1-weighted 
anatomical MR scans were acquired (3D MPRAGE, TR=9.95ms, TE=5.6ms, flip-angle=8º, 
1x1x1mm3 voxels, number of slices=160, total scan-time=10m14s).  
 DID patients and healthy controls (HCs) were scanned interleaved (i.e., alternating 
between patients and healthy controls) within a short time interval. Final samples were 
distributed relatively equally over the three centers, with 10 patients and 17 HC included 
from the UMCG, 7 patients and 11 HC from the AMC, and 15 patients and 15 HC from 
Zurich. The number of participants in each group also did not differ across centers (Chi 
square=1.01, p=0.603).  
 
Image preprocessing 
After quality control checks, structural images were preprocessed using the SPM8 software 
(http://www.fil.ion.ucl.ac.uk/spm/, release 4667). They were first segmented into different 
tissue types via the “new segment” tool31, which is part of the voxel based morphology 
(VBM) processing pipeline. Rigidly aligned grey and white matter maps, down-sampled to 
1.5 mm isotropic voxel size, were then used to diffeomorphically register all subjects to their 
common average (i.e., study-specific template), using a matching term that assumed a 
multinomial distribution32. Registration involved estimating a set of initial velocities, from 
which the deformations were computed by a geodesic shooting procedure33. Classification 
was based on a set of “scalar momentum” image features derived from this registration, 
which describe anatomical variability amongst subjects34. These images contain all 
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information necessary to reconstruct the original images (in addition to the template) and 
therefore provide a parsimonious representation of shape difference. The scalar momentum 
images for grey and white matter were spatially smoothed with an isotropic 10mm Gaussian 
kernel and concatenated prior to classification. This choice of feature construction method 
and smoothing level was based on previous work, where smoothed scalar momentum 
images yielded greater accuracy than a range of alternative features (including Jacobian 
determinants, rigidly aligned grey matter, spatially normalised grey matter and Jacobian 
scaled spatially normalised grey matter) for predicting subject age and sex in a publicly 
available dataset35 and for discriminating neurological disorders from structural MRI35.  
 
Pattern Recognition 
Binary Gaussian process classifiers (GPCs36) were used as the primary analytical approach 
for this study. GPCs are a supervised pattern recognition approach that assigns a predictive 
probability of group membership to each individual based on a set of “training” data. They 
are kernel classifiers similar to the widely used Support Vector Machines (SVMs) and have 
shown high levels of performance for neuroimaging data37–39. Moreover, GPCs have 
advantages over SVMs in that the probabilistic predictions they provide encode a measure 
of predictive confidence that quantifies diagnostic uncertainty and can capture variability 
within clinical groups. More importantly, probabilistic predictions can be easily adjusted to 
compensate for the prior frequency of diagnostic classes in experimental populations. This 
means that inference remains coherent in classification scenarios where the frequency of 
each class in the test set is different from the frequencies observed in the training set and is 
useful to accommodate variations in disease prevalence40 and to compensate for 
unbalanced training datasets41 as outlined below. These properties are particularly important 
for the present study because the classes are unbalanced and the number of samples 
available for training is small.  
Linear binary GPCs were used to discriminate DID patients from healthy controls. 
Technical details surrounding GPC inference have been presented elsewhere37. A leave-
one-subject-out cross-validation approach was used to assess classifier generalizability, 
whereby a single subject was excluded to comprise the test set, and all parameters were 
inferred from the remaining data (training set), before applying this classifier to predict the 
labels for the test samples. Prior to classification, a t-test was used to select a set of 
discriminant voxels using a fixed threshold of p < 0.001. This was repeated excluding each 
subject once. Importantly, feature selection was performed using the training data only, 
which ensures the classifier remains unbiased. 
 Classifier performance was evaluated using receiver operating characteristic (ROC) 
curves derived from the probabilistic predictions and classification accuracy, which measures 
9 
the classifier performance in a categorical sense. To derive categorical predictions from the 
probabilistic predictions obtained from the GPC, the probabilistic predictions were 
thresholded according to the frequency of classes in the training set (i.e. 0.5 if the classes 
are balanced). Classifier assessment metrics included the sensitivity and specificity in 
addition to the positive and negative predictive value (PPV/NPV). Finally the (balanced) 
accuracy was computed as the mean of sensitivity and specificity, which quantifies the 
overall categorical classification performance of the classifier in a way that accommodates 
potential class imbalance in the data. 
   
Forward maps of regional class differences  
To understand the relative importance of different brain regions underlying the classification 
decision, we employed a forward mapping strategy42. This has advantages over the more 
commonly used strategy of directly mapping the weight vector43. Specifically, a voxel may 
have a high weight because of an association with the class labels or as a result of high 
collinearity between voxels, where the high weight may help to cancel out noise or mismatch 
in other voxels. In contrast, the coefficients from the forward modeling approach proposed 
by Haufe and colleagues42 represent the group differences between classes, which are more 
often of interest when interpreting a trained classifier. In this case stronger positive values in 
a forward map indicate a stronger association of a region with the DID (“Favouring DID”), 
that is, increased volume of a brain area in DID, while negative values indicate a stronger 
association with HCs (“Favouring HC”), that is, decreased volume of a brain area in DID. 
Note that only voxels surviving the univariate feature selection step are included in the map 
and that the GPC discriminates data on the basis of the whole pattern. Hence, local 
inferences based on these approaches should be made with caution. In order to report 
results in standard MNI coordinates the DARTEL group tissue template (GM, WM and CSF) 
was coregistered to a SPM8 new_segment segmentation of the FSL MNI152_T1_1mm 
template brain. Advanced normalisation tools (ANTS version 2.1.044) were used to calculate 
a non-linear transformation employing the SyN algorithm (antsRegistrationSyN.sh, default 
parameters) using multimodal information from the 3 channels (CSF, GM and WM). The 
results of the registration were visually inspected and appeared to be a significant 
improvement on a simple affine registration. We selected the cluster peaks of the forward 
maps in terms of X, Y, and Z coordinates on the basis of the maximum (absolute) coefficient. 
Anatomical labels were derived by AATSR, SC and YRS from a consensus of different 
atlases.  
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RESULTS 
Classification 
Using the imaging data, the classifier discriminated between DID and HC groups with high 
sensitivity (71.88%) and specificity (73.81%), yielding an overall balanced accuracy of 
72.84%, which was significantly higher than the accuracy expected by chance (p < 0.01, 
permutation test). Receiver operating characteristic analysis (see Figure 1) further 
demonstrated that classification performance was above chance across all decision 
thresholds and yielded an area under the curve of 0.74. The forward maps for the grey and 
white matter components are displayed in Figure 2. Brain areas contributing to the 
classification are listed in Table 1.  
 
Relative decrease in regional volume in the DID group 
For grey matter, the pattern of voxels favouring HC, that is a relative increase for the HC 
group or in other words a relative decrease in the DID group, included bilateral middle, 
superior, and dorsolateral frontal gyrus, left medial and right orbito-frontal gyrus, bilateral 
anterior cingulate gyrus, bilateral middle temporal gyrus, bilateral fusiform gyrus, right 
inferior temporal gyrus, left inferior parietal lobule and supramarginal gyrus, and bilateral 
superior occipital gyrus.  
 For white matter, the pattern of voxels favouring HC included the bilateral inferior 
fronto-occipital tract, the left corticospinal tract, and the right superior and left inferior 
longitudinal fasciculus. In addition, the white matter of the right inferior, bilateral middle and 
superior frontal regions, bilateral temporal, cerebellar, and lateral occipital regions, and of 
the left amygdala-hippocampal junction, and (anterior) cingulate were also included in the 
distinguishing pattern. 
 
Relative increase in regional volume for the DID group 
For grey matter the pattern of voxels favouring DID was found to be far less pronounced 
than that of favouring HC, and included left superior frontal gyrus, left medial parietal lobule, 
and bilateral cerebellum. 
 The pattern of voxels in the white matter of the brain favouring DID included left 
inferior and superior longitudinal fasciculus, the left inferior fronto-occipital fasciculus, and 
the right corticospinal tract. In addition, the white matter of bilateral (anterior) cingulate and 
insula regions, bilateral inferior, medial and superior frontal regions, left parietal regions and 
putamen, right inferior and middle temporal regions and bilateral cerebellum were included. 
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DISCUSSION 
Main findings 
This is the first study to demonstrate that individuals with DID and healthy controls can be 
differentiated at the level of individual subjects with a high level of accuracy on the basis of 
their neuroanatomical markers. This discrimination was based on neuroanatomical data in 
the largest sample of individuals with DID included in a brain imaging study to date. We 
found widespread grey and white matter spatially dependent patterns of abnormal brain 
morphology in individuals with DID as compared to healthy controls. These findings are 
important because they provide evidence for a biological basis for distinguishing between 
genuine DID and healthy controls. The current study also provides support for the 
development of pattern recognition methodologies as a clinically useful diagnostic tool in 
DID thereby paving the way for future studies with a diagnostic aim in distinguishing 
between genuine DID and other psychopathologies.  
 
Comparison to other studies 
Despite the reported high prevalence of DID of approximately 6% in psychiatric outpatients45 
and 1-3% of the general population46, neurobiological studies on DID are scarce17,19,47 and 
depend on mass-univariate data-analysis approaches, which provide inferences at the group 
level. Mass-univariate data-analysis ignore information encoded by spatially distributed 
patterns of morphological abnormalities throughout the brain and have limited ability to 
provide inferences at the level of individual participants. In contrast, multivariate data-
analysis techniques using pattern classification methodology allow for the study of 
underlying patterns of effects and the distribution across brain regions, and more 
importantly, they provide predictions that quantify group separation at the level of individual 
subjects on the basis of patterns of abnormality in the data, which may be clinically useful10. 
 Pattern recognition methods are becoming widely used for neuroimaging-based 
psychiatric diagnostics10. Our study shows that DID patients can be distinguished from 
healthy controls at an individual level with a sensitivity of 71.88% and specificity of 73.81%. 
This level of accuracy is comparable to what has been demonstrated for most psychiatric 
disorders10, including psychosis48. Our results provide evidence that DID has a biological 
basis that allows individuals with DID to be separated from controls at the level of individual 
subjects. This is important because of the controversy surrounding DID as a diagnostic 
entity2. Skeptics of DID assume that dissociative symptoms can easily be simulated by 
normal healthy individuals and they argue that subjects can manipulate their brain 
activity15,16. As neuroanatomical data is unlikely to be subject to cognitive manipulation the 
current study challenges the core of the Fantasy Model for DID by providing evidence that 
genuine DID can be distinguished from normal healthy individuals on the basis of their brain 
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morphology. Currently the DID diagnosis is made based solely on clinical interview and 
observation. Unfamiliarity with the spectrum of dissociative disorders, validity concerns of 
DID, the existence of imitative DID, or lack of knowledge and appreciation of the 
epidemiology could lead to under- and misdiagnosis by clinicians4. High comorbidity rates 
complicate the diagnosis even further. Applying pattern recognition methods to brain imaging 
data of DID patients offers a biomarker approach that can complement, aid and improve 
clinical decision making. This could reduce misdiagnoses, treatment time, treatment costs, 
and ultimately improve patient’s quality of life. 
 
Neuroanatomical biomarkers 
According to the Trauma Model11 DID is an early-onset form of post-traumatic stress 
disorder (PTSD)11,17,18 . Early life stressors may have long-lasting detrimental effects on 
neurobiology due to altered stress reactivity following childhood trauma19. Earlier 
neuroanatomical studies in DID have focused on, and found, smaller hippocampal volume, 
which seems to be the results of exposure to stress hormones due to antecedent 
traumatization. Although it is currently unknown how early traumatization affects the 
development of the brain19 it is not surprising that long-lasting trauma results in a 
widespread patterns of affected grey and white matter brain regions. We found affected 
brain regions in different lobules in the brain, but most prominently in the frontal grey and 
white matter regions, supporting findings from previous studies investigating the 
neuroanatomical correlates of dissociative symptoms across disorders17,49–51 using 
univariate data-analysis approaches. Interestingly, the pattern of affected grey matter 
structural regions in the current study shows overlap with regions found in functional brain 
imaging studies involving dissociation, which included different patient samples and different 
paradigms, such as resting state in dissociative PTSD52, script-driven imagery in DID14 or 
emotion processing in depersonalization disorder53, but consistently reported functional 
aberrations in frontal regions of the brain. Models of trauma-related dissociation14,52 propose 
important roles for the cingulate gyrus, medial prefrontal cortex, and superior frontal regions 
in emotion under-/overregulation and dissociation. The current multivariate study in the most 
severe form of dissociative disorders found that structural aberrations of these brain regions 
are part of the identified spatially distributed pattern. We therefore propose that future 
research into dissociation and DID focuses on these specific prefrontal areas, as well as the 
middle and dorsolateral prefrontal cortex, as important candidate regions for 
identifying neurobiomarkers of dissociation and specifically of DID.  
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Limitations 
Our study has several strengths and limitations. First, while the findings show that DID 
patient can be distinguished from healthy controls at an individual level with a high sensitivity 
and specificity, future studies are needed to unravel how individuals with DID differ from their 
most common misdiagnosed psychopathologies, such as borderline personality disorder and 
schizophrenia. We recommend that such future studies carefully debrief past psychiatric and 
neurological history including depressive and/or psychotic episodes, history of epilepsy, and 
duration of treatment, because these factors are likely to improve the ability for differential 
diagnostics of the classifier. The validation of the complex pattern recognition system with 
respect to these factors is important for clinical utilization and will need large patient samples 
of a wide variety of psychopathology. Furthermore, we recommend that future studies 
include a PTSD group without dissociative symptoms to investigate how PTSD co-morbidity 
affects the classification, both at the level of the clinical presentation and biology. However, it 
is important to note that there is negligible overlap between results from the only multivariate 
study in PTSD54 and our results, indicating that the multivariate patterns found in the current 
study are likely to be dissociation-specific neuroanatomical biomarkers. Second, we 
employed a multicentre acquisition protocol to overcome single-site recruitment limitations, 
but carefully matched MRI acquisition parameters across sites using a study optimized 
scanning sequence30. We further accounted for inter-site effects during the data-analyses by 
standardizing the data within each site separately prior to classification, which speaks 
against the possibility that inter-site effects can be fully attributed to site effects. Third, only 
women volunteered to participate in the study and therefore the results cannot be extended 
to all DID patients. Most of these women were currently using medication or had used 
medication in the past (see Supplementary Table 1). However, because medication use was 
highly variable across subjects it is unlikely that the effects on grey and white matter will be 
consistent, as previously reported in a separate study of our group17. Nevertheless, even 
though this is the case in the current study it is recommended that future studies 
systematically investigate whether neuroanatomical changes are related to psychotropic 
medication. 
 
Conclusions 
In sum, our results reveal patterns of neuroanatomical alterations which overlap with 
previous findings from functional brain imaging studies. We propose a pattern of 
neuroimaging biomarkers that could be used to inform the identification of individuals with 
DID from healthy controls at the individual level. Furthermore, the current study supports the 
development of pattern recognition methodologies as a clinically useful diagnostic tool and 
paves the way for future studies that distinguish between DID and other psychopathologies. 
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This is important and clinically relevant because the DID diagnosis is controversial and 
individuals with DID are often misdiagnosed. Ultimately, the application of pattern recognition 
methodologies could prevent unnecessary suffering of individuals with DID because of an 
earlier accurate diagnosis, which will facilitate faster and targeted interventions.  
 
  
15 
ACKNOWLEDGEMENTS 
This paper represents independent research part funded by the National Institute for Health 
Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS 
Foundation Trust and King’s College London. The views expressed are those of the 
author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. 
A.A.T.S. Reinders was supported by the Netherlands Organization for Scientific Research 
(www.nwo.nl), NWO-VENI grant no. 451-07-009. S. Chalavi is supported by a David Caul 
graduate research grant from the International Society for the Study of Trauma and 
Dissociation (ISSTD) (http://www.isst-d.org/about/awards.htm). Andre F. Marquand 
gratefully acknowledges support from the King's College London Centre of Excellence in 
Medical Engineering, funded by the Wellcome Trust and EPSRC and from a VIDI fellowship 
from the NWO (grant no. 016.156.415). Yolanda Schlumpf was supported by the 
Forschungskredit of the University of Zurich. The authors would like to thank all the 
participants and their therapists. We also would like to thank Nel Draijer, Mechteld Giesen, 
Ekaterina Weder, and Eva Zimmermann for participant inclusion and scanning and Andrew 
Lawrence for coordinate transformation into MNI space and preparing the Tables.  
 
 
AUTHOR CONTRIBUTIONS 
1) Conception and design: A.A.T.S.R., Y.R.S., E.M.V., E.R.S.N., P.D., L.J., D.J.V. 
2) Analysis and interpretation of data: A.A.T.S.R., A.F.M., S.C., D.J.V. 
3) Drafting the article: A.A.T.S.R., A.F.M., D.J.V. 
4) Critical revision for important intellectual content: S.C., Y.R.S., E.M.V., E.R.S.N., P.D., L.J. 
3) Final approval of the version to be published: A.A.T.S.R., A.F.M., S.C., Y.R.S., E.M.V., 
E.R.S.N., P.D., L.J., D.J.V. 
 
 
16 
REFERENCES 
1  Gillig PM. Dissociative identity disorder: a controversial diagnosis. Psychiatry 2009; 6: 
24–9. 
2  Dalenberg CJ, Brand BL, Loewenstein RJ, Gleaves DH, Dorahy MJ, Cardeña E, et al. 
Reality versus fantasy: reply to Lynn et al. (2014). Psychol Bull 2014; 140: 911–20. 
3  Brand BL, Vissia EM, Chalavi S, Nijenhuis ERS, Webermann AR, Draijer N, et al. DID 
is trauma based: further evidence supporting the trauma model of DID. Acta Psychiatr 
Scand 2016; 134: 560–3. 
4  Chu JA, Dell PF, Van der Hart O, Cardeña E, Barach PM, Somer E, et al. Guidelines 
for Treating Dissociative Identity Disorder in Adults, Third Revision - International 
Society for the Study of Trauma and Dissociation. J Trauma Dissociation 2011; 12: 
115–87. 
5  Piper A, Merskey H. The persistence of folly: a critical examination of dissociative 
identity disorder. Part I. The excesses of an improbable concept. Can J Psychiatry 
2004; 49: 592–600. 
6  Pope HG, Barry S, Bodkin A, Hudson JI. Tracking scientific interest in the dissociative 
disorders: a study of scientific publication output 1984-2003. Psychother Psychosom 
2006; 75: 19–24. 
7  Sar V. Epidemiology of Dissociative Disorders: An Overview. Epidemiol Res Int 2011; 
1: 1–8. 
8  Lloyd M. Reducing the cost of dissociative identity disorder: Measuring the 
effectiveness of specialized treatment by frequency of contacts with mental health 
services. J Trauma Dissociation 2016; 17: 362–70. 
9  Myrick AC, Webermann AR, Langeland W, Putnam FW, Brand BL. Treatment of 
dissociative disorders and reported changes in inpatient and outpatient cost 
estimates. Eur J Psychotraumatol 2017; 8: 1375829. 
10  Wolfers T, Buitelaar JK, Beckmann C, Franke B, Marquand AF. From estimating 
activation locality to predicting disorder: a review of pattern recognition for 
neuroimaging-based psychiatric diagnostics. Neurosci Biobehav Rev 2015; 57: 328–
49. 
11  Vissia EM, Giesen ME, Chalavi S, Nijenhuis ERS, Draijer N, Brand BL, et al. Is it 
Trauma- or Fantasy-based? Comparing dissociative identity disorder, post-traumatic 
stress disorder, simulators, and controls. Acta Psychiatr Scand 2016; 134: 111–28. 
12  Schlumpf YR, Nijenhuis ERS, Chalavi S, Weder E V, Zimmermann E, Luechinger R, 
et al. Dissociative part-dependent biopsychosocial reactions to backward masked 
angry and neutral faces: An fMRI study of dissociative identity disorder. NeuroImage 
Clin 2013; 3: 54–64. 
17 
13  Schlumpf YR, Reinders AATS, Nijenhuis ERS, Luechinger R, van Osch MJP, Jäncke 
L. Dissociative part-dependent resting-state activity in dissociative identity disorder: a 
controlled FMRI perfusion study. PLoS One 2014; 9: e98795. 
14  Reinders AATS, Willemsen ATM, Vissia EM, Vos HPJ, den Boer JA, Nijenhuis ERS. 
The Psychobiology of Authentic and Simulated Dissociative Personality States: The 
Full Monty. J Nerv Ment Dis 2016; 204: 445–57. 
15  Zotev V, Phillips R, Young KD, Drevets WC, Bodurka J. Prefrontal control of the 
amygdala during real-time fMRI neurofeedback training of emotion regulation. PLoS 
One 2013; 8: e79184. 
16  Kim S, Birbaumer N. Real-time functional MRI neurofeedback: a tool for psychiatry. 
Curr Opin Psychiatry 2014; 27: 332–6. 
17  Chalavi S, Vissia EM, Giesen ME, Nijenhuis ERS, Draijer N, Barker GJ, et al. Similar 
cortical but not subcortical gray matter abnormalities in women with posttraumatic 
stress disorder with versus without dissociative identity disorder. Psychiatry Res 2015; 
231: 308–19. 
18  Chalavi S, Vissia EM, Giesen ME, Nijenhuis ERS, Draijer N, Cole JH, et al. Abnormal 
hippocampal morphology in dissociative identity disorder and post-traumatic stress 
disorder correlates with childhood trauma and dissociative symptoms. Hum Brain 
Mapp 2015; 36: 1692–704. 
19  Reinders AATS, Chalavi S, Schlumpf YR, Vissia EM, Nijenhuis ERS, Jäncke L, et al. 
Neurodevelopmental origins of abnormal cortical morphology in dissociative identity 
disorder. Acta Psychiatr Scand 2017. doi:10.1111/acps.12839. 
20  APA. American Psychiatric Association: Diagnostic and Statistical Manual of Mental 
Disorders, DSM-5. Am. Psychiatr. Assoc. 2013; : Fifth Edition. Arlington, VA. 
21  Boon S, Draijer N. Multiple personality disorder in The Netherlands: a clinical 
investigation of 71 patients. Am J Psychiatry 1993; 150: 489–94. 
22  Steinberg M. Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-
D). American Psychiatric Press, 1993. 
23  Draijer N, Boon S. The Imitation of Dissociative Identity Disorder: Patients at Risk, 
Therapists at Risk. J Psychiatry Law 1999; 27: 423–58. 
24  Rodewald F, Wilhelm-G?ling C, Emrich HM, Reddemann L, Gast U. Axis-I 
Comorbidity in Female Patients With Dissociative Identity Disorder and Dissociative 
Identity Disorder Not Otherwise Specified. J Nerv Ment Dis 2011; 199: 122–31. 
25  Bozkurt H, Duzman Mutluer T, Kose C, Zoroglu S. High psychiatric comorbidity in 
adolescents with dissociative disorders. Psychiatry Clin Neurosci 2015; 69: 369–74. 
26  Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation 
scale. J Nerv Ment Dis 1986; 174: 727–35. 
18 
27  Nijenhuis ERS, Spinhoven P, Van Dyck R, Van der Hart O, Vanderlinden J. The 
development and psychometric characteristics of the Somatoform Dissociation 
Questionnaire (SDQ-20). J Nerv Ment Dis 1996; 184: 688–94. 
28  Sierra M, Berrios GE. The Cambridge Depersonalization Scale: a new instrument for 
the measurement of depersonalization. Psychiatry Res 2000; 93: 153–64. 
29  Nijenhuis ERS, Van der Hart O, Kruger K. The psychometric characteristics of the 
Traumatic Experiences Checklist (TEC): first findings among psychiatric outpatients. 
Clin Psychol Psychother 2002; 9: 200–10. 
30  Chalavi S, Simmons A, Dijkstra H, Barker GJ, Reinders AA. Quantitative and 
qualitative assessment of structural magnetic resonance imaging data in a two-center 
study. BMC Med Imaging 2012; 12: 27. 
31  Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005; 26: 839–51. 
32  Ashburner J, Friston KJ. Computing average shaped tissue probability templates. 
Neuroimage 2009; 45: 333–41. 
33  Ashburner J, Friston KJ. Diffeomorphic registration using geodesic shooting and 
Gauss-Newton optimisation. Neuroimage 2011; 55: 954–67. 
34  Singh N, Fletcher PT, Preston JS, Ha L, King R, Marron JS, et al. Multivariate 
Statistical Analysis of Deformation Momenta Relating Anatomical Shape to 
Neuropsychological Measures. In 13th International Conference on Medical Image 
Computing and Computer-Assisted Intervention, MICCAI 2010: 529–37. , 2010. 
35  Marquand AF, Filippone M, Ashburner J, Girolami M, Mourao-Miranda J, Barker GJ, et 
al. Automated, High Accuracy Classification of Parkinsonian Disorders: A Pattern 
Recognition Approach. PLoS One 2013; 8. doi:10.1371/journal.pone.0069237. 
36  Rasmussen CE, Rasmussen CE. Gaussian processes for machine learning. 2006. 
(http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.86.3414). 
37  Marquand A, Howard M, Brammer M, Chu C, Coen S, Mourão-Miranda J. 
Quantitative prediction of subjective pain intensity from whole-brain fMRI data using 
Gaussian processes. Neuroimage 2010; 49: 2178–89. 
38  Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using Support Vector 
Machine to identify imaging biomarkers of neurological and psychiatric disease: a 
critical review. Neurosci Biobehav Rev 2012; 36: 1140–52. 
39  Schrouff J, Rosa MJ, Rondina JM, Marquand AF, Chu C, Ashburner J, et al. PRoNTo: 
Pattern Recognition for Neuroimaging Toolbox. Neuroinformatics 2013; 11: 319. 
40  Hahn T, Marquand AF, Plichta MM, Ehlis A-C, Schecklmann MW, Dresler T, et al. A 
Novel Approach to Probabilistic Biomarker-Based Classification Using Functional 
Near-Infrared Spectroscopy. Hum Brain Mapp 2013; 34: 1102. 
41  Lim HK, Jung WS, Ahn KJ, Won WY, Hahn C, Lee SY, et al. Regional cortical 
19 
thickness and subcortical volume changes are associated with cognitive impairments 
in the drug-naive patients with late-onset depression. Neuropsychopharmacology 
2012; 37: 838–49. 
42  Haufe S, Meinecke F, Gorgen K, Dahne S, Haynes J-D, Blankertz B, et al. On the 
interpretation of weight vectors of linear models in multivariate neuroimaging. 
Neuroimage 2014; 87: 96–110. 
43  Mourão-Miranda J, Bokde ALW, Born C, Hampel H, Stetter M. Classifying brain states 
and determining the discriminating activation patterns: Support Vector Machine on 
functional MRI data. Neuroimage 2005; 28: 980–95. 
44  Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible 
evaluation of ANTs similarity metric performance in brain image registration. 
Neuroimage 2011; 54: 2033–44. 
45  Foote B, Smolin Y, Kaplan M, Legatt ME, Lipschitz D. Prevalence of dissociative 
disorders in psychiatric outpatients. Am J Psychiatry 2006; 163: 623–9. 
46  Sar V, Akyüz G, Doğan O. Prevalence of dissociative disorders among women in the 
general population. Psychiatry Res 2007; 149: 169–76. 
47  Dorahy MJ, Brand BL, Sar V, Krüger C, Stavropoulos P, Martínez-Taboas A, et al. 
Dissociative identity disorder: An empirical overview. Aust N Z J Psychiatry 2014; 48: 
402–17. 
48  Mourao-Miranda J, Reinders AATS, Rocha-Rego V, Lappin J, Rondina J, Morgan C, 
et al. Individualized prediction of illness course at the first psychotic episode: a 
support vector machine MRI study. Psychol Med 2012; 42: 1037–47. 
49  Nardo D, Högberg G, Lanius RA, Jacobsson H, Jonsson C, Hällström T, et al. Gray 
matter volume alterations related to trait dissociation in PTSD and traumatized 
controls. Acta Psychiatr Scand 2013; 128: 222–33. 
50  Sierra M, Nestler S, Jay E-L, Ecker C, Feng Y, David AS. A structural MRI study of 
cortical thickness in depersonalisation disorder. Psychiatry Res Neuroimaging 2014; 
224: 1–7. 
51  Daniels JK, Frewen P, Theberge J, Lanius RA. Structural brain aberrations associated 
with the dissociative subtype of post-traumatic stress disorder. Acta Psychiatr Scand 
2016; 133: 232–40. 
52  Lanius RA, Vermetten E, Loewenstein RJ, Brand B, Schmahl C, Bremner JD, et al. 
Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative 
subtype. Am J Psychiatry 2010; 167: 640–7. 
53  Lemche E, Anilkumar A, Giampietro VP, Brammer MJ, Surguladze SA, Lawrence NS, 
et al. Cerebral and autonomic responses to emotional facial expressions in 
depersonalisation disorder. Br J Psychiatry 2008; 193: 222–8. 
20 
54  Gong Q, Li L, Tognin S, Wu Q, Pettersson-Yeo W, Lui S, et al. Using structural 
neuroanatomy to identify trauma survivors with and without post-traumatic stress 
disorder at the individual level. Psychol Med 2014; 44: 195–203. 
 
 
21 
TABLE LEGEND 
Table 1  
Grey and white matter patterns of affected brain regions. DID < HC: negative values in a 
forward map indicate a stronger association with HCs (“Favouring HC”), that is, a relative 
decreased volume of a brain area in DID. DID > HC: positive values in a forward map 
indicate a stronger association of a region with the DID (“Favouring DID”), that is, relative 
increased volume of a brain area in DID. Only clusters larger than an arbitrary threshold of 
eight voxels14 are shown.  
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TABLE 1          
          
   L/R BA X Y Z Volume MAX 
DID < HC *          
 GREY MATTER         
    Frontal         
  I. Frontal gyrus L 47 -27.3 25.0 -16.7 1889 20300 
  M. Frontal gyrus L 10 -25.0 63.5 10.5 50 14900 
  M. Frontal gyrus R 10 37.4 58.2 16.4 324 16800 
  M. Frontal gyrus R 8 45.0 14.7 52.7 366 19000 
  M. Frontal gyrus/Orbito-Frontal gyrus R 11 23.0 16.5 -14.5 319 18400 
  Medial Frontal gyrus L 10 -4.5 64.0 -13.5 112 15200 
  Medial Frontal gyrus L 9 -4.5 56.0 40.5 98 17800 
  S./Medial Frontal gyrus L 10 -6.0 65.5 22.5 31 15900 
  S. Frontal gyrus L 6 -6.7 1.5 73.3 40 14900 
  S. Frontal sulcus L 6 -23.0 17.3 66.3 18 13400 
  S. Frontal sulcus R 6 26.5 5.5 70.0 188 16000 
  S. Frontal gyrus R 9 8.0 53.0 45.0 172 19700 
  S. Frontal gyrus R 8 7.5 42.0 56.0 25 11900 
  Dorsolateral prefrontal cortex/M. Frontal Gyrus L 9/46 -51.0 23.5 33.5 814 18600 
  Dorsolateral prefrontal cortex/M. Frontal Gyrus L 9/46 -40.5 41.0 2.5 75 15700 
  Dorsolateral prefrontal cortex/M. Frontal Gyrus R 9/46 44.5 30.3 15.7 324 16300 
  Cingulate gyrus L 24 -9.0 3.0 35.0 70 17100 
  Anterior Cingulate Gyrus L 24 -6.5 37.5 5.5 105 16400 
  Anterior Cingulate Gyrus R 24/32 20.0 36.3 21.3 444 17100 
  Precentral gyrus L 4 -55.0 -9.5 51.5 126 16700 
    Parietal         
  I. Parietal lobule L 40 -50.5 -54.0 54.0 25 15000 
  I. Parietal lobule L 40 -59.0 -33.5 50.5 18 13900 
  Supramarginal gyrus L 40 -63.0 -47.3 33.3 16 17000 
    Occipital         
  I. Occipital gyrus L 18 -38.3 -89.7 -15.7 50 15400 
  M. Occipital gyrus L 19 -55.5 -71.0 -9.5 306 18500 
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  S. Occipital sulcus L 19 -36.0 -87.0 32.5 47 16300 
  S. Occipital gyrus R 19 42.0 -83.0 32.0 30 15700 
    Temporal         
  I. Temporal gyrus R 20 45.3 1.5 -43.8 99 18700 
  I. Temporal gyrus/Fusiform gyrus R 37 49.5 -72.0 -4.5 135 14200 
  I. Temporal gyrus/Fusiform gyrus R 20 49.8 -18.4 -23.4 10 14400 
  M. Temporal gyrus R 21 61.3 -35.0 -5.3 259 17500 
  M./S. Temporal gyrus L 21/38 -52.6 5.2 -13.4 26 13200 
  M./S. Temporal gyrus R 21/38 38.0 13.5 -41.5 140 16000 
  Fusiform gyrus L 37 -40.0 -46.5 -6.5 171 15100 
    Other         
        None  
          
 WHITE MATTER         
    Tracts         
  I. Longitudional fasciculus L  -38.7 -45.7 -15.3 70 0.0669 
  S. Longitudinal fasciculus (temporal part) R  62.6 -37.4 -12.4 181 0.1720 
  Corticospinal tract L  -21.0 -17.5 9.5 24 0.0807 
  I. Frontal-Occipital fasciculus L  -26.0 24.5 16.5 101 0.1190 
  I. Frontal-Occipital fasciculus L  -27.0 37.0 3.0 38 0.0686 
  I. Frontal-Occipital fasciculus R  23.0 34.5 25.5 214 0.1120 
    Frontal         
  I. Frontal WM R  23.0 14.5 -19.5 179 0.1150 
  M. Frontal WM R  58.0 32.3 18.3 73 0.0481 
  M. Frontal WM L  -53.0 17.0 41.5 488 0.1880 
  M. Frontal WM R  49.5 12.0 52.5 183 0.1060 
  M./S. Frontal WM R  44.7 48.7 25.5 61 0.0900 
  S. Frontal WM L  -11.5 70.5 0.0 76 0.1170 
  S. Frontal WM L  -4.5 47.0 52.5 56 0.1350 
  S. Frontal WM L  -24.0 33.0 56.0 37 0.1160 
  S. Frontal WM L  -6.0 68.3 22.3 31 0.1060 
  S. Frontal WM L  -23.0 17.3 66.3 18 0.0938 
  S. Frontal WM L  -25.5 65.5 7.5 12 0.0207 
  S. Frontal WM R  24.3 1.0 72.3 111 0.2170 
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  S. Frontal WM R  9.0 50.0 50.0 103 0.1920 
  S. Frontal WM R  23.4 68.8 10.4 27 0.0898 
  S. Frontal WM R  9.3 38.0 59.7 25 0.2630 
  S. Frontal/Premotor WM R  8.0 17.0 70.0 54 0.1580 
  S. Frontal/Premotor WM L  -6.5 1.5 76.0 40 0.1990 
  Anterior Cingulate WM L  -5.6 34.2 4.4 73 0.0713 
  Cingulate WM L  -7.5 -0.5 33.5 12 0.0112 
  Precentral WM L  -47.6 1.6 52.6 85 0.0771 
  Insular WM R  29.0 21.5 13.5 36 0.0686 
    Parietal         
  I. Parietal lobule L  -57.0 -33.5 53.5 13 0.0844 
    Occipital         
  Lateral Occipital WM L  -53.0 -70.0 -10.5 268 0.1300 
  Lateral Occipital WM (inferior division) L  -40.5 -89.5 -11.5 50 0.1430 
  Lateral Occipital WM (superior division) L  -36.5 -83.0 34.5 47 0.1130 
  Lateral Occipital WM (superior division) R  40.3 -75.3 46.0 30 0.1050 
  Lateral Occipital WM R  52.0 -74.0 -11.0 124 0.1760 
    Temporal         
  I. Temporal gyrus (anterior division) R  47.0 -8.5 -45.0 40 0.0444 
  Temporal pole L  -42.0 17.5 -34.0 98 0.0890 
  Temporal pole L  -54.0 13.0 -19.0 21 0.1090 
  Temporal pole R  31.5 13.3 -41.7 140 0.2670 
    Other         
  Amygdala/Hippocampus L  -26.5 -7.0 -20.5 1286 0.2750 
  Cerebellum (Crus I) L  -32.8 -71.6 -33.0 61 0.0792 
  Cerebellum (Crus I) R  37.5 -63.5 -34.0 85 0.0857 
          
          
DID > HC **          
 GREY MATTER         
    Frontal         
  S. Frontal sulcus L 4/6 -19.5 -13.0 58.5 19 10600 
    Parietal         
  Medial posterior parietal L 7 -14.7 -58.0 57.7 16 14700 
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  Medial posterior parietal/Precuneus L 7 -14.5 -71.0 57.0 14 15200 
    Occipital         
        None  
    Temporal         
        None  
    Other         
  Cerebellum (Crus I) L  -37.5 -72.0 -33.0 686 15500 
  Cerebellum (Crus I) R  42.5 -63.5 -37.0 285 16900 
  Periaqueductal grey L  -2.5 -30.5 -11.0 58 15000 
          
 WHITE MATTER         
    Tracts         
  I. Longitudinal fasciculus L  -41.5 -47.0 -4.5 98 0.1060 
  I. Longitudinal fasciculus L  -42.5 -5.0 -20.5 14 0.0369 
  S. Longitudinal fasciculus L  -50.5 -52.5 54.0 22 0.0608 
  S. Longitudinal fasciculus L  -19.5 -14.4 61.0 19 0.3820 
  Corticospinal tract R  16.3 -2.7 9.5 438 0.2030 
  Inferior Fronto-Occipital fasciculus L  -39.9 40.6 0.6 37 0.1390 
    Frontal         
  I. Frontal WM L  -32.5 23.7 -19.7 58 0.0835 
  I. Frontal WM L  -21.7 12.0 -18.3 37 0.0399 
  I. Frontal WM (pars triangularis) R  56.7 28.7 13.5 250 0.1070 
  M. Frontal WM R  44.0 17.7 51.7 174 0.1520 
  Medial Frontal WM L  -4.6 54.6 40.6 42 0.0950 
  Medial Frontal/Forceps minor L  -7.8 62.6 -11.6 35 0.0564 
  Medial Frontal/Forceps minor R  6.5 54.7 37.7 65 0.1820 
  S. Frontal WM L  -33.7 29.0 48.7 274 0.1390 
  S. Frontal WM L  -25.5 64.0 14.5 37 0.0903 
  S. Frontal WM R  36.0 55.7 19.7 233 0.1720 
  S. Frontal/Premotor WM R  22.3 9.5 65.5 18 0.0396 
  Precentral/Premotor WM L  -46.5 2.5 46.5 27 0.1040 
  Precentral /Premotor WM L  -56.4 -7.8 49.4 14 0.0527 
  Cingulate WM L  -11.0 8.0 36.5 57 0.1240 
  Anterior Cingulate WM L  -7.8 38.4 0.6 31 0.0572 
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  Cingulate WM/Forceps minor R  15.4 31.4 25.8 207 0.1120 
  Insula WM L  -31.5 23.5 11.0 172 0.1480 
  Insula WM R  33.5 29.5 9.0 97 0.1210 
    Parietal         
  Superior Parietal lobule L  -15.0 -55.5 53.5 16 0.2130 
  Supramarginal WM (posterior division) L  -63.0 -47.3 33.3 16 0.0923 
  Precuneus WM L  -14.0 -69.5 53.5 14 0.1860 
    Occipital         
  M. Occipital WM R  45.4 -70.4 -4.3 9 0.0510 
    Temporal         
  Temporal pole L  -33.4 14.4 -38.6 98 0.0626 
  I. Temporal WM (anterior division) R  46.6 1.4 -45.4 56 0.0755 
  M. Temporal WM R  49.0 -34.0 -8.0 77 0.1490 
  Fusiform WM L  -49.2 -66.6 -17.4 36 0.0401 
    Other         
  Cerebellum (Crus I) L  -45.5 -55.0 -28.0 624 0.3260 
  Cerebellum (Crus I) R  44.5 -65.3 -41.3 195 0.1170 
  Putamen L  -31.0 -12.0 1.0 312 0.2000 
  Brainstem (Midbrain) L  -7.0 -29.0 -9.5 58 0.1650 
          
          
  * = Favouring HC; negative values in the 
forward map 
       
  ** = Favouring DID; positive values in the 
forward map 
       
  M. = Middle        
  I. = Inferior        
  S. = Superior        
  (x, y, z) = coordinates in MNI space        
  Volume in voxels        
  MAX = weight vector score        
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FIGURES & FIGURE LEGENDS 
Figure 1 
Receiver operating characteristic curve for discriminating between DID subjects and HCs. The 
dotted line indicates chance level and the solid line is constructed by varying the decision 
threshold smoothly between 0 and 1, plotting true positive rate (sensitivity) against false positive 
rate (1 – specificity). Points northwest of the dotted line indicate above chance discrimination. 
The area under the curve (AUC) summarises classifier performance across all decision 
thresholds. 
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Figure 2 
Forward map showing the underlying pattern of abnormality differentiating DID from normal 
healthy controls for grey (Figure 2A) and white (Figures 2B) matter. Coefficient images are 
overlaid on the study-specific anatomical templates in axial views. Images are scaled such that 
the maximum value in each image was equal to one, and only regions surviving the feature 
selection step are shown. Positive coefficients indicate a positive association in favour of DID, 
while negative coefficients indicate a positive association in favour of healthy controls.  
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SUPPLEMENTARY MATERIALS 
 
Table presenting participant demographics 
 
Supplementary Table 1: Participant demographics and clinical characteristics. These data have been previously reported in a similar manner. 
 
   All   
   mean (std)  ttest 
   DID-G (n=32) HC (n=43) p-value 
 Demographics     
  Age 43.56 (9.34) 42.28 (11.57) 0.608 
  Education 14.31 (2.04) 14.84 (1.63) 0.220 
  Medication^    
     anti-psychotics: n(typical,atypical) (4,12) 0 NA 
     anti-epileptics: n  5 0 NA 
     anti-depressants: n 21 0 NA 
 Clinical measures     
  Tramatic Experiences Checklist (TEC)    
     emotional neglect 12.28 (2.58) 2.60 (4.39) <0.001 
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     emotional abuse 11.86 (3.26) 1.53 (3.23) <0.001 
     physical abuse 11.69 (3.63) 0.60 (1.99) <0.001 
     sexual harrasment 10.07 (4.29) 0.52 (1.57) <0.001 
     sexual abuse 10.38 (4.41) 0.07 (0.34) <0.001 
     total  18.45 (3.97) 3.14 (2.78) <0.001 
  Dissociative symptoms    
     psychoform (DES) 50.14 (17.94) 6.31 (5.07) <0.001 
     somatoform (SDQ-20) 52.77 (16.32) 22.45 (2.41) <0.001 
  Depersonalization symptoms (CDS)    
     frequency 1.72 (0.67) 0.22 (0.16) <0.001 
     duration  2.28 (1.11) 0.34 (0.35) <0.001 
     total 117.47 (48.60) 16.60 (13.87) <0.001 
      
      
  ^ = past and present medication use    
  DES = Dissociation Experience Scale    
  SDQ-20 = Somatoform Dissociation Questionnaire    
  CDS = Cambridge Depersonalisation Scale    
 
 
